Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bhagwan Yadav

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Hemasphere|March 2, 2022
Targeting Apoptosis Pathways With BCL2 and MDM2 Inhibitors in Adult B-cell Acute Lymphoblastic LeukemiaHelena Hohtari, Matti Kankainen, Shady Adnan-Awad, et al.
Leukemia|December 21, 2018
Dasatinib and navitoclax act synergistically to target NUP98-NSD1<sup>+</sup>/FLT3-ITD<sup>+</sup> acute myeloid leukemiaJarno L Kivioja, Angeliki Thanasopoulou, Ashwini Kumar, et al.
Oncotarget|December 13, 2017
Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK/STAT3 signalingHeikki Kuusanmäki, Olli Dufva, Elina Parri, et al.
Leukemia|July 18, 2020
KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemiaDisha Malani, Bhagwan Yadav, Ashwini Kumar, et al.
Oncotarget|September 17, 2017
Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testingMuntasir Mamun Majumder, Raija Silvennoinen, Pekka Anttila, et al.
Scientific Reports|June 6, 2014
Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapiesBhagwan Yadav, Tea Pemovska, Agnieszka Szwajda, et al.
Molecular Cancer Therapeutics|July 5, 2018
Drug-Sensitivity Screening and Genomic Characterization of 45 HPV-Negative Head and Neck Carcinoma Cell Lines for Novel Biomarkers of Drug EfficacyTatiana Lepikhova, Piia-Riitta Karhemo, Riku Louhimo, et al.
NPJ Systems Biology and Applications|July 18, 2019
Network pharmacology modeling identifies synergistic Aurora B and ZAK interaction in triple-negative breast cancerJing Tang, Prson Gautam, Abhishekh Gupta, et al.
Haematologica|July 13, 2019
Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemiaHeikki Kuusanmäki, Aino-Maija Leppä, Petri Pölönen, et al.
Gynecologic Oncology|January 21, 2017
Systematic drug sensitivity testing reveals synergistic growth inhibition by dasatinib or mTOR inhibitors with paclitaxel in ovarian granulosa cell tumor cellsUlla-Maija Haltia, Noora Andersson, Bhagwan Yadav, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Hemasphere|March 2, 2022
Targeting Apoptosis Pathways With BCL2 and MDM2 Inhibitors in Adult B-cell Acute Lymphoblastic LeukemiaHelena Hohtari, Matti Kankainen, Shady Adnan-Awad, et al.
Leukemia|December 21, 2018
Dasatinib and navitoclax act synergistically to target NUP98-NSD1<sup>+</sup>/FLT3-ITD<sup>+</sup> acute myeloid leukemiaJarno L Kivioja, Angeliki Thanasopoulou, Ashwini Kumar, et al.
Oncotarget|December 13, 2017
Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK/STAT3 signalingHeikki Kuusanmäki, Olli Dufva, Elina Parri, et al.
Leukemia|July 18, 2020
KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemiaDisha Malani, Bhagwan Yadav, Ashwini Kumar, et al.
Oncotarget|September 17, 2017
Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testingMuntasir Mamun Majumder, Raija Silvennoinen, Pekka Anttila, et al.
Scientific Reports|June 6, 2014
Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapiesBhagwan Yadav, Tea Pemovska, Agnieszka Szwajda, et al.
Molecular Cancer Therapeutics|July 5, 2018
Drug-Sensitivity Screening and Genomic Characterization of 45 HPV-Negative Head and Neck Carcinoma Cell Lines for Novel Biomarkers of Drug EfficacyTatiana Lepikhova, Piia-Riitta Karhemo, Riku Louhimo, et al.
NPJ Systems Biology and Applications|July 18, 2019
Network pharmacology modeling identifies synergistic Aurora B and ZAK interaction in triple-negative breast cancerJing Tang, Prson Gautam, Abhishekh Gupta, et al.
Haematologica|July 13, 2019
Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemiaHeikki Kuusanmäki, Aino-Maija Leppä, Petri Pölönen, et al.
Gynecologic Oncology|January 21, 2017
Systematic drug sensitivity testing reveals synergistic growth inhibition by dasatinib or mTOR inhibitors with paclitaxel in ovarian granulosa cell tumor cellsUlla-Maija Haltia, Noora Andersson, Bhagwan Yadav, et al.
Pageof 4